Make Your Portfolio Healthier with American Well Stock at New 2-Year Highs
Make Your Portfolio Healthier with American Well Stock at New 2-Year Highs.
American Well (AMWL) demonstrates strong technical momentum, recently hitting a new 2-year high.
AMWL maintains a 100% "Buy" technical opinion from Barchart.
Despite an 18.85% projected revenue decline this year, earnings are expected to rise 16.01% this year and 37.31% next year.
Valued at $208 million, American Well (AMWL) delivers hybrid healthcare in the United States and abroad. Its Converge platform helps providers offer in-person, online, and automated care, and helps patients manage chronic conditions, among other things.
I found today's Chart of the Day by using Barchart's powerful screening functions to sort for stocks with the highest technical buy signals; superior current momentum in both strength and direction, Weighted Alpha above 50+ and a 60-Month Beta over 1.5. I then used Barchart's Flipcharts feature to review the charts for consistent price appreciation. AMWL checks those boxes. The Trend Seeker issued a new "Buy" signal on April 16. Since then, the stock has gained 103.39%.
Huge, Unusual Intel Options Volume Today Ahead of Earnings This Week
Intel Stock Is Down, But Put Premiums are High - Put Short Sellers Love the High Yields
The Number Tesla Stock Bulls Are Really Waiting for This Earnings Season Has Nothing to Do With Cars
Editor's Note: The technical indicators below are updated live during the session every 20 minutes and can therefore change each day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com website when you read this report. These technical indicators form the Barchart Opinion on a particular stock.
The stock recently traded at $12.38 with a 50-day moving average of $9.05.
AMWL has made 12 new highs and gained 49.95% over the past month.
Revenue is projected to decrease 18.85% this year but increase again by 3.12% next year.
Earnings are estimated to increase 16.01% this year and an additional 37.31% next year.
The Wall Street analysts followed by Barchart give the stock 1 "Strong Buy" and 7 "Hold" opinions with price targets between $6.50 and $9.00.
Morningstar thinks the stock is 10% undervalued with a fair value of $13.23.
8,830 investors are following the stock on Seeking Alpha, which rates it a "Hold."
Short interest is a low 1.06% of the float with 2.23 days to cover the float.
Although the company hasn't had increases in revenue, it has enjoyed increases in earnings and cash flow from operations and is predicted to continue that trend.
